83 related articles for article (PubMed ID: 26935349)
21. Elimination of tilmicosin in lactating ewes.
Atef M; Abo el-Sooud K; Nahed E; Tawfik M
Dtsch Tierarztl Wochenschr; 1999 Jul; 106(7):291-4. PubMed ID: 10481373
[TBL] [Abstract][Full Text] [Related]
22. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
[TBL] [Abstract][Full Text] [Related]
23. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.
Messenger KM; Papich MG; Blikslager AT
J Vet Pharmacol Ther; 2012 Oct; 35(5):452-9. PubMed ID: 21913941
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of tylosin in broiler chickens.
Kowalski C; Roliński Z; Zań R; Wawron W
Pol J Vet Sci; 2002; 5(3):127-30. PubMed ID: 12448074
[TBL] [Abstract][Full Text] [Related]
25. Comparative pharmacokinetics and bioavailability of tylosin tartrate and tylosin phosphate after a single oral and i.v. administration in chickens.
Ji LW; Dong LL; Ji H; Feng XW; Li D; Ding RL; Jiang SX
J Vet Pharmacol Ther; 2014 Jun; 37(3):312-5. PubMed ID: 24325541
[TBL] [Abstract][Full Text] [Related]
26. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum.
Clark C; Woodbury M; Dowling P; Ross S; Boison JO
J Vet Pharmacol Ther; 2004 Oct; 27(5):385-7. PubMed ID: 15500580
[No Abstract] [Full Text] [Related]
27. Tylosin depletion in edible tissues of turkeys.
Montesissa C; De Liguoro M; Santi A; Capolongo F; Biancotto G
Food Addit Contam; 1999 Oct; 16(10):405-10. PubMed ID: 10755131
[TBL] [Abstract][Full Text] [Related]
28. Impact of the type of catheter on the absorption of tylvalosin (acetylvaleryltylosin) administered orally to broiler chickens.
Cerdá RO; Petruccelli M; Piscopo M; Origlia J; Landoni M
J Vet Pharmacol Ther; 2010 Apr; 33(2):202-3. PubMed ID: 20444046
[No Abstract] [Full Text] [Related]
29. Pharmacokinetics and tissue depletion of tilmicosin in turkeys.
Fricke JA; Clark CR; Boison JO; Chirino-Trejo M; Inglis TE; Dowling PM
J Vet Pharmacol Ther; 2008 Dec; 31(6):591-4. PubMed ID: 19000285
[No Abstract] [Full Text] [Related]
30. Determination of in vivo protein synthesis in human palatine tonsil.
Januszkiewicz A; Klaude M; Loré K; Andersson J; Ringdén O; Rooyackers O; Wernerman J
Clin Sci (Lond); 2005 Feb; 108(2):179-84. PubMed ID: 15535800
[TBL] [Abstract][Full Text] [Related]
31. Variation in water disappearance, daily dose, and synovial fluid concentrations of tylvalosin and 3-O-acetyltylosin in commerical pigs during five day water medication with tylvalosin under field conditions.
Canning P; Bates J; Skoland K; Coetzee J; Wulf L; Rajewski S; Wang C; Gauger P; Ramirez A; Karriker L
J Vet Pharmacol Ther; 2018 Aug; 41(4):632-636. PubMed ID: 29572923
[TBL] [Abstract][Full Text] [Related]
32. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.
Villarino N; Lesman S; Fielder A; García-Tapia D; Cox S; Lucas M; Robinson J; Brown SA; Martín-Jiménez T
J Vet Pharmacol Ther; 2013 Aug; 36(4):329-39. PubMed ID: 23072251
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of cefquinome in pigs.
Zhao DH; Zhang CY; Zhang Z; Liu ZC; Liu BT; Yu JJ; Guo JP; Deng H; Liu YH
J Vet Pharmacol Ther; 2013 Aug; 36(4):313-9. PubMed ID: 23189984
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tissue residues of an oxytetracycline/diclofenac combination in cattle.
Mestorino N; Mariño Hernández E; Marchetti L; Errecalde JO
Rev Sci Tech; 2007 Dec; 26(3):679-90. PubMed ID: 18293616
[TBL] [Abstract][Full Text] [Related]
36. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.
Modric S; Webb AI; Davidson M
Lab Anim Sci; 1999 Jun; 49(3):248-53. PubMed ID: 10403438
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.
Jetlund O; Thurmann-Nielsen E; Walstad RA
Int J Clin Pharmacol Res; 1991; 11(1):1-6. PubMed ID: 1908443
[TBL] [Abstract][Full Text] [Related]
38. Concentrations of flurithromycin in serum and tonsils.
Galioto GB; Mevio E; Galioto P; Zanuso G; Lepore AM
Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):126-8. PubMed ID: 2722307
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.
Villarino N; Lesman S; Fielder A; García-Tapia D; Cox S; Lucas M; Robinson J; Brown SA; Martín-Jiménez T
J Vet Pharmacol Ther; 2013 Aug; 36(4):340-9. PubMed ID: 23067107
[TBL] [Abstract][Full Text] [Related]
40. The acute phase response induced by Escherichia coli lipopolysaccharide modifies the pharmacokinetics and metabolism of florfenicol in rabbits.
Pérez R; Palma C; Burgos R; Jeldres JA; Espinoza A; Peñailillo AK
J Vet Pharmacol Ther; 2016 Apr; 39(2):183-90. PubMed ID: 26010096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
